Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease

Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease

A novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), or 2019 novel coronavirus] has been identified as the pathogen of coronavirus disease 2019. The main protease (Mpro, also called 3‐chymotrypsin‐like protease) of SARS‐CoV‐2 is a potential target for treatment of COVID...

Full description

Bibliographic Details
Main Author:	Motonori Tsuji
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	FEBS Open Bio
Subjects:	2019 novel coronavirus COVID‐19 drug repositioning Mpro SARS‐CoV‐2 virtual screening
Online Access:	https://doi.org/10.1002/2211-5463.12875

Similar Items

ChEMBL-Likeness Score and Database GDBChEMBL
by: Sven Bühlmann, et al.
Published: (2020-02-01)

The Immobilization of ChEMBL474807 Molecules Using Different Classes of Nanostructures
by: Przemysław Czeleń, et al.
Published: (2019-08-01)

Deorphaning anti-tuberculosis compounds using chemogenomic approaches and data from the ChEMBL database
by: G. Mugumbate, et al.
Published: (2014-04-01)

In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease
by: Michael Alabboud, et al.
Published: (2020-07-01)

The Possible Molecular Mechanism of SARS-CoV-2 Main Protease: New Structural Insights from Computational Methods
by: Alvea Tasneem, et al.
Published: (2021-01-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

ChEMBL Beaker: A Lightweight Web Framework Providing Robust and Extensible Cheminformatics Services
by: Michał Nowotka, et al.
Published: (2014-11-01)

In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
by: Simone Di Micco, et al.
Published: (2021-01-01)

Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
by: Nitish Kumar, et al.
Published: (2021-11-01)

A Plasmodium falciparum protein tyrosine phosphatase inhibitor identified from the ChEMBL‐NTD database blocks parasite growth
by: Rajan Pandey, et al.
Published: (2021-07-01)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
by: Divya M. Teli, et al.
Published: (2021-01-01)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>)
by: Ahmed M. Sayed, et al.
Published: (2020-06-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
by: Eelke B. Lenselink, et al.
Published: (2017-08-01)

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
by: Muhammad Usman Mirza, et al.
Published: (2020-08-01)

Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates
by: Taufik Muhammad Fakih
Published: (2021-07-01)

Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins
by: Fazlur Rahman, et al.
Published: (2021-03-01)

Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19
by: Hayate Javed, et al.
Published: (2021-02-01)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
by: Asim Kumar Bepari, et al.
Published: (2021-04-01)

Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities.
by: Richard D Cramer
Published: (2015-01-01)

Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach
by: Mycal Dutta, et al.
Published: (2021-05-01)

Is Pakistan's Response to Coronavirus (SARS-CoV-2) Adequate to Prevent an Outbreak?
by: Bilal Javed, et al.
Published: (2020-04-01)

Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2
by: Cristina Loras, et al.
Published: (2020-04-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Tackling the SARS-CoV-2 main protease using hybrid derivatives of 1,5-disubstituted tetrazole-1,2,3-triazoles: an in silico assay
by: Carlos J. Cortés-García, et al.
Published: (2020-06-01)

Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
by: Sukanya Panikar, et al.
Published: (2021-05-01)

Different Cases of SARS-CoV-2 Infection and Its Impact on Health and Economy with Special Emphasis on Antiviral Drug Targets
by: Hiran Kanti Santra, et al.
Published: (2020-05-01)

Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold
by: Alshaimaa M. Hamoda, et al.
Published: (2021-05-01)

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
by: Syed Faraz Ahmed, et al.
Published: (2020-02-01)

Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system
by: Nengzhuang Wang, et al.
Published: (2021-04-01)

The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis
by: Kuma Diriba, et al.
Published: (2020-09-01)

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
by: Ting Xiao, et al.
Published: (2021-06-01)

Potential inhibitors for targeting Mpro and Spike of SARS-CoV-2 based on sequence and structural pharmacology analysis
by: Chuanjun Shu, et al.
Published: (2020-04-01)

Click triazole as a linker for drug repurposing against SARs-CoV-2: A greener approach in race to find COVID-19 therapeutic
by: Satyaki Chatterjee, et al.
Published: (2021-01-01)

An Overview of COVID-19 and the Potential Plant Harboured Secondary Metabolites against SARS-CoV-2: A Review
by: C.T. Swamy
Published: (2021-09-01)

SARS-CoV-2 M<sup>pro</sup>: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
by: Andrea Citarella, et al.
Published: (2021-04-01)

SARS-CoV-2 and COVID-19: The most important research questions
by: Kit-San Yuen, et al.
Published: (2020-03-01)

Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States
by: Erxi Wu, et al.
Published: (2020-12-01)